FDA.reportPublic FDA data

Application 013026

Type
NDA
Sponsor
WYETH PHARMS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
002TRECATORETHIONAMIDETABLET;ORAL250MGYesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0008-4117TrecatorethionamideWyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.NDACurrent
0008-4117TrecatorethionamideWyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.NDACurrent
0008-4117TrecatorethionamideWyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.NDACurrent
0008-4117TrecatorethionamideWyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.NDACurrent
0008-4117TrecatorethionamideWyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.NDACurrent
0008-4117TrecatorethionamideWyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
75001SUPPL 2023-08-04
74989SUPPL 2023-08-04
45108SUPPL2016-08-23
45156SUPPL2016-08-22
33101SUPPL2006-06-20
353SUPPL2006-06-20
33100SUPPL2004-11-15
10829SUPPL2004-11-15
352SUPPL2004-11-15
351SUPPL2004-11-15